Target intelligence / Profile preview

Amyloid P component, serum pseudogene

Molecular classification: Other (Pseudogene; not classified as receptor, enzyme, transporter, transcription factor, etc.)

Overview

The "amyloid P component, serum pseudogene" (ENSG00000231100) is a genetically inactive locus classified as a pseudogene, lacking the ability to encode a functional serum amyloid P component protein. Its presence is likely due to gene duplication events. While the protein-coding gene *APCS* is widely studied for its role in amyloidosis and is considered a drug target, this pseudogene does not produce functional protein and is not considered a therapeutic target. Reference to this entry as a target is incorrect; inquiries pertaining to a therapeutic target should refer instead to "Amyloid P component, serum" (APCS, ENSG00000132703)[5][3][1].

Other names: Amyloid P component, serum pseudogeneAPCS pseudogene

Beyond the preview

Go deeper on Amyloid P component, serum pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid P component, serum pseudogene.

Explore the full profile